Melchior MB, van Osch MH, Graat RM, van Duijkeren E, Mevius DJ, Nielen M, Gaastra W,
Fink-Gremmels J (2009) Biofilm formation and genotyping of Staphylococcus aureus bovine
mastitis isolates: Evidence for lack of penicillin-resistance in Agr-type II strains. Vet Microbiol
137:83–89
Merrikin DJ, Briant J, Rolinson GN (1983) Effect of protein binding on antibiotic activity in vivo.
J Antimicrob Chemother 11:233–238
Moroni P, Pisoni G, Antonini M, Villa R, Boettcher P, Carli S (2006) Short communication:
Antimicrobial drug susceptibility ofStaphylococcus aureusfrom subclinical bovine mastitis in
Italy. J Dairy Sci 89:2973–2976
Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL (2005) Standardization of pharma-
cokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J Anti-
microb Chemother 55:601–607
Naber KG (2001) Which fluoroquinolones are suitable for the treatment of urinary tract infections?
Int J Antimicrob Agents 17:331–341
Nadell CD, Xavier JB, Foster KR (2009) The sociobiology of biofilms. FEMS Microbiol Rev
33:206–224
Nicolau DP (2001) Predicting antibacterial response from pharmacodynamic and pharmacokinetic
profiles. Infection 29(Suppl 2):11–5
Noel AR, Bowker KE, MacGowan AP (2007) Variability in the size of the fluoroquinolone AUC/
MIC for antibacterial effect in S. aureus: Impact for clinical breakpoints. Abstract 47th
ICAAC, Chicago, USA, abstract A-23 pp5-6
O’Brien TF (2002) Emergence, spread, and environmental effect of antimicrobial resistance: How
use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else.
Clin Infect Dis 34(Suppl 3):S78–S84
Opal SM (2007) Communal living by bacteria and the pathogenesis of urinary tract infections.
PLoS Med 4:e349
Owens RC, Ambrose PG (2007) Antimicrobial stewardship and the role of pharmacokinetics-
pharmacodynamics in the modern antibiotic era. Diagn Microbiol Infect Dis 57(3 Suppl):
77S–83S
Periti P, Mazzei T (1998) Antibiotic-induced release of bacterial cell wall components in the
pathogenesis of sepsis and septic shock: A review. J Chemother 10:427–448
Peterson MM, Mack JL, Hall PR, Alsup AA, Alexander SM, Sully EK, Sawires YS, Cheung AL,
Otto M, Gresham HD (2008) Apolipoprotein B is an innate barrier against invasive Staphylo-
coccus aureus infection. Cell Host Microbe 4:555–566
Pfaller MA (2006) Flavophospholipol use in animals: Positive implications for antimicrobial
resistance based on its microbiologic properties. Diagn Microbiol Infect Dis 56:115–121
Phillips I (2007) Withdrawal of growth-promoting antibiotics in Europe and its effects in relation
to human health. Int J Antimicrob Agents 30:101–107
Phillips I, Casewell M, Cox T, De Groot B, Friis C, Jones R, Nightingale C, Preston R, Waddell J
(2004a) Does the use of antibiotics in food animals pose a risk to human health? A critical
review of published data. J Antimicrob Chemother 53:28–52
Phillips I, Casewell M, Cox T, De Groot B, Friis C, Jones R, Nightingale C, Preston R, Waddell J
(2004b) Does the use of antibiotics in food animals pose a risk to human health? A reply to
critics. J Antimicrob Chemother 54:276–278
Potter T, Illambas J, Rycroft AN, Brentnall C, McKellar QA, Lees P (2009a) Integration and
modeling of pharmacokinetic and pharmacodynamic data for oxytetracycline in calves. J Vet
Pharmacol Ther 32(Suppl 1):66–67
Potter T, Illambas J, Rycroft AN, Lees P (2009b) Integration and modeling of pharmacokinetic
and pharmacodynamic data for marbofloxacin in calves. J Vet Pharmacol Ther 32(Suppl 1):
142–143
Prescott JF, Baggot JD (1993) Aminoglycosides and aminocyclitols. In: Prescott JF, Baggot JD
(eds) Antimicrobial therapy in veterinary medicine, 2nd edn. Iowa State University Press,
Ames, IA, pp 144–178
262 M. Martinez and P. Silley